Back to Search Start Over

[Neurology : what's new in 2021].

Authors :
Vicino A
Allali G
Bally J
Castro Jimenez M
Chiabotti Salvioni P
Hirt L
Hottinger A
Michel P
Novy J
Pot Kreis C
Rossetti A
Rouaud O
Ryvlin P
Théaudin M
Du Pasquier R
Source :
Revue medicale suisse [Rev Med Suisse] 2022 Jan 19; Vol. 18 (764-5), pp. 51-55.
Publication Year :
2022

Abstract

In 2021, we assisted to the publication of new diagnostic criteria, classifications, and guidelines (CIDP, brain tumors, auto-immune encephalitis). Several studies helped to define the pharmacological management of focal and generalized epileptic seizures and epilepsy in pregnant women. The availability of biomarkers and the approval of immunotherapies are modifying the landscape of dementia management. Endovascular interventions without previous thrombolysis seems to be effective in anterior circulation acute ischemic stroke (AIS) and severe posterior circulation AIS. Neurologic complications of Sars-CoV-2 infection were further studied, as well as the efficacy of vaccines in immunosuppressed patients. New molecules and techniques show promising results for the treatment of migraine and cluster headache.<br />Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.

Details

Language :
French
ISSN :
1660-9379
Volume :
18
Issue :
764-5
Database :
MEDLINE
Journal :
Revue medicale suisse
Publication Type :
Academic Journal
Accession number :
35048580
Full Text :
https://doi.org/10.53738/REVMED.2022.18.764-65.51